Jazz Pharmaceuticals plc: Jazz Pharmaceuticals to Present New Data at SLEEP 2022 Reinforcing Leadership in Sleep Medicine

Seventeen abstracts debut new data across narcolepsy and idiopathic hypersomnia DUBLIN, June 1, 2022 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company

Related Keywords

Wisconsin ,United States ,Ireland ,Dublin ,Kristin Bhavnani ,Kelvin Tan ,Andrean Flynn ,Jazz Pharmaceuticals Inc ,Jazz Pharmaceuticals ,Drug Administration ,United States Drug Enforcement Agency ,Office Of Orphan Product Development ,Head Of Global Corporate Communications ,Us Drug Enforcement Agency ,Nasdaq ,Prnewswire Jazz Pharmaceuticals ,Narcolepsy Assessment Partnership ,Associated Professional Sleep Societies ,Session Title ,Enhanced Machine Learning Algorithm ,Clinician Notification ,Routine Sleep Medicine ,Safety During ,Clinical Trial ,Lower Sodium Oxybate ,Participants With Narcolepsy ,Transitioning From Sodium Oxybate ,People With Narcolepsy ,Data From ,Patients With ,Interim Data From ,Narcolepsy Detection Paradigm ,Automated Nocturnal Detection ,Sleep Onset Rapid Eye Movement ,Their Providers ,Pediatric Narcolepsy Registry ,Patients With Idiopathic ,Idiopathic Hypersomnia ,Response Based ,Epworth Sleepiness Scale ,Idiopathic Hypersomnia Severity Scale ,Satisfaction With ,Diagnostic Process ,Disease Burden ,Patients With Idiopathic Hypersomnia ,Without Long Sleep Time ,Real World Idiopathic Hypersomnia Outcomes Study ,Wisconsin Sleep ,Romantic Relationships ,Orphan Drug Exclusivity ,Orphan Product Development ,Enforcement Agency ,Risk Evaluation ,Mitigation Strategy ,Prescribing Information ,Boxed Warning ,Global Corporate ,Palo Alto ,States Drug Enforcement ,Accessed December ,Jazz ,Pharmaceuticals ,Present ,Data ,Sleep ,022 ,Reinforcing ,Leadership ,Medicine ,